Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI
· Real-Time Price · USD
14.71
0.25 (1.73%)
At close: Aug 15, 2025, 3:59 PM
14.60
-0.71%
After-hours: Aug 15, 2025, 07:56 PM EDT
Denali Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | -305.04M | -303.78M | -9.65M | 25.49M | 340.81M | 343.11M | 101.46M | 108.46M | 110.69M | 112.42M | 82.88M | 48.66M | 352.96M | 357.07M | 339.98M |
Cost of Revenue | n/a | 1.94M | 4.1M | 6.28M | 8.5M | 7.91M | 14.92M | 15.97M | 15.03M | 14.91M | 7.03M | 5.12M | 75.4M | 139.88M | 198.79M | 252.22M | 234.37M | 221.81M |
Gross Profit | n/a | -1.94M | -4.1M | -311.32M | -312.27M | -17.57M | 10.57M | 324.84M | 328.07M | 86.56M | 101.43M | 105.58M | 37.02M | -57M | -150.13M | 100.74M | 122.7M | 118.17M |
Operating Income | -533.58M | -515.21M | -501.88M | -504.6M | -495.21M | -208.14M | -196.7M | -169.47M | -163.16M | -395.06M | -340.74M | -312.52M | -290.63M | -291.03M | -295.75M | 25.45M | 50.92M | 51.47M |
Interest Income | 43.77M | 61.33M | 64.64M | 62.6M | 61.05M | 56.38M | 51.51M | 45.04M | 34.78M | 24.53M | 14.77M | 9.4M | 6.22M | 4.69M | 4.59M | 4.94M | 5.88M | 7.35M |
Pretax Income | -478.97M | -453.87M | -422.7M | -427.46M | -419.62M | -137.22M | -145.19M | -124.44M | -128.38M | -370.53M | -325.97M | -303.12M | -284.41M | -286.33M | -291.16M | 30.39M | 56.8M | 58.82M |
Net Income | -479.03M | -453.94M | -422.77M | -427.49M | -419.65M | -137.25M | -145.22M | -124.43M | -128.38M | -370.55M | -324.71M | -301.3M | -282.58M | -284.48M | -290.58M | 29.57M | 55.92M | 57.86M |
Selling & General & Admin | 116.63M | 107.61M | 101.33M | 93.87M | 94.24M | 97.11M | 101.18M | 102.1M | 100.03M | 95.07M | 90.47M | 88.72M | 84.78M | 82.66M | 79.06M | 75.29M | 71.78M | 66.71M |
Research & Development | 416.95M | 405.65M | 396.44M | 404.46M | 395.95M | 402.08M | 423.88M | 408.18M | 406.23M | 401.45M | 358.73M | 334.5M | 318.27M | 291.24M | 265.35M | 252.22M | 234.37M | 221.81M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 533.58M | 513.26M | 497.77M | 498.32M | 490.2M | 499.19M | 525.05M | 510.29M | 506.27M | 496.52M | 449.21M | 423.21M | 403.05M | 373.91M | 344.41M | 327.51M | 306.14M | 288.51M |
Interest Expense | n/a | n/a | n/a | 21.08M | 21.08M | 21.08M | 21.08M | 6.66M | 10.85M | 10.85M | 10.85M | 4.19M | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | -1.94M | -4.1M | -6.28M | -6.28M | -4.34M | -2.18M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 406.82M | 523.41M | 510.09M | 504.6M | 496.48M | 503.53M | 527.23M | 510.29M | 506.27M | 496.52M | 449.21M | 423.21M | 403.05M | 373.91M | 344.41M | 327.51M | 306.14M | 288.51M |
Income Tax Expense | 68K | 68K | 2.19M | 2.15M | 2.15M | 2.15M | 30K | -6K | -6K | 21K | -1.26M | -1.83M | -1.04M | -1.07M | 207K | 1.6M | 879K | 958K |
Shares Outstanding (Basic) | 171.45M | 171.22M | 170.09M | 169.46M | 168.83M | 149.4M | 138.25M | 137.64M | 137.05M | 136.52M | 132.88M | 123.47M | 122.49M | 122.67M | 122.16M | 121.74M | 121.29M | 120.76M |
Shares Outstanding (Diluted) | 171.45M | 171.22M | 170.09M | 169.46M | 168.83M | 149.4M | 138.25M | 137.64M | 140.93M | 136.52M | 132.88M | 123.47M | 123.01M | 122.67M | 122.16M | 121.74M | 123.01M | 120.88M |
EPS (Basic) | -2.8 | -2.67 | -2.57 | -2.76 | -2.85 | -0.92 | -1.04 | -0.92 | -1.04 | -2.86 | -2.58 | -2.46 | -2.31 | -2.33 | -2.39 | 0.27 | 0.42 | 0.36 |
EPS (Diluted) | -2.8 | -2.67 | -2.57 | -2.76 | -2.85 | -0.96 | -1.08 | -0.96 | -1.08 | -2.86 | -2.58 | -2.46 | -2.31 | -2.32 | -2.38 | 0.15 | 0.30 | 0.23 |
EBITDA | -525.48M | -505.16M | -492.89M | -496.02M | -486.68M | -201.55M | -182.23M | -153.12M | -146.88M | -376.71M | -330.36M | -306.23M | -284.29M | -284.56M | -289.25M | 34.07M | 59.51M | 59.99M |
EBIT | -383.45M | -500.05M | -486.72M | -504.6M | -495.21M | -195.24M | -183.8M | -156.57M | -150.26M | -395.06M | -340.74M | -312.52M | -290.63M | -291.03M | -295.75M | 27.08M | 52.55M | 53.09M |
Depreciation & Amortization | 8.1M | 10.04M | 8.99M | 8.55M | 8.5M | 7.91M | 14.92M | 15.97M | 15.03M | 14.91M | 7.03M | 5.12M | 5.24M | 5.49M | 5.61M | 6.42M | 7.17M | 7.84M |